PapersFlow Research Brief
Prion Diseases and Protein Misfolding
Research Guide
What is Prion Diseases and Protein Misfolding?
Prion diseases and protein misfolding refer to a group of fatal neurodegenerative disorders caused by the conformational conversion of cellular prion protein (PrP^C) into pathogenic scrapie PrP (PrP^Sc), leading to protein aggregation, amyloid formation, and transmissible spongiform encephalopathies such as scrapie, bovine spongiform encephalopathy, and variant Creutzfeldt-Jakob disease.
Research on prion diseases and protein misfolding encompasses 46,171 works focused on molecular mechanisms, detection, transmission, and treatments, including variant Creutzfeldt-Jakob disease and infectious prions. Prusiner (1982) identified novel proteinaceous infectious particles as the cause of scrapie, demonstrating protease sensitivity and the requirement of protein for infectivity in "Novel Proteinaceous Infectious Particles Cause Scrapie". Prusiner (1998) detailed prions as infectious pathogens causing genetic, infectious, or sporadic neurodegenerative diseases through PrP modification in "Prions".
Topic Hierarchy
Research Sub-Topics
Prion Protein Misfolding Mechanisms
This sub-topic examines the structural transitions of cellular prion protein (PrPC) to its pathogenic scrapie form (PrPSc), including nucleation-polymerization models and conformational changes. Researchers investigate biophysical techniques like NMR and molecular dynamics simulations to elucidate folding pathways.
Protein Misfolding Cyclic Amplification
This sub-topic covers PMCA techniques for amplifying prions in vitro, enabling ultrasensitive detection without bioassays. Researchers refine protocols for different prion strains and apply PMCA to diagnostics and strain typing.
Variant Creutzfeldt-Jakob Disease
This sub-topic focuses on vCJD epidemiology, clinical features, and its link to bovine spongiform encephalopathy via human consumption. Studies analyze neuropathology, diagnostic biomarkers, and long-term surveillance post-exposure.
Prion Strain Diversity
Researchers study distinct prion strains with unique incubation periods, lesion profiles, and conformational properties despite identical protein sequences. Investigations use animal models and cell assays to characterize strain properties and interspecies transmission.
Cellular Prion Protein Functions
This sub-topic explores physiological roles of PrPC in copper binding, neuroprotection, and synaptic plasticity using knockout models. Researchers probe signaling pathways and disease-independent functions in immunity and hematopoiesis.
Why It Matters
Prion diseases propagate via protein misfolding where PrP^Sc templates misfolding of PrP^C, leading to neurodegeneration observable in scrapie-affected sheep and goats after prolonged incubation, as shown by Prusiner (1982) in "Novel Proteinaceous Infectious Particles Cause Scrapie". This mechanism extends to human conditions like variant Creutzfeldt-Jakob disease, transmissible through blood transfusion, highlighting risks in medical practices. Protein misfolding also underlies amyloidopathies; Chiti and Dobson (2006) linked it to neurodegenerative disorders and systemic amyloidoses in "Protein Misfolding, Functional Amyloid, and Human Disease", while Hardy and Selkoe (2002) connected amyloid β-peptide accumulation to Alzheimer's progression in "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics", affecting over 10 years of research on plaque deposition driving tau pathology.
Reading Guide
Where to Start
"Novel Proteinaceous Infectious Particles Cause Scrapie" by Prusiner (1982), as it provides foundational evidence for proteinaceous infectivity in prion diseases through protease sensitivity and six evidential lines, establishing core concepts before broader misfolding applications.
Key Papers Explained
Prusiner (1982) in "Novel Proteinaceous Infectious Particles Cause Scrapie" identified protein-based scrapie agents, built upon by Prusiner (1998) in "Prions" explaining PrP modification across genetic, infectious, and sporadic forms including bovine spongiform encephalopathy. Chiti and Dobson (2006) in "Protein Misfolding, Functional Amyloid, and Human Disease" generalized misfolding to amyloidoses and neurodegeneration. Hardy and Selkoe (2002) in "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics" applied this to Aβ-driven Alzheimer's, extended by Selenica et al. (2012) showing Aβ oligomers exacerbate tau pathology in "Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy".
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes cyclic amplification for prion detection and blood transfusion transmissibility risks, as noted in the topic description, alongside protein aggregation in transmissible spongiform encephalopathies. No recent preprints or news available indicate focus remains on established molecular pathology from top papers.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Amyloid Hypothesis of Alzheimer's Disease: Progress and Pr... | 2002 | Science | 13.6K | ✕ |
| 2 | Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of... | 2012 | Neurodegenerative Dise... | 10.4K | ✓ |
| 3 | Protein Misfolding, Functional Amyloid, and Human Disease | 2006 | Annual Review of Bioch... | 6.3K | ✕ |
| 4 | Alzheimer's disease: Initial report of the purification and ch... | 1984 | Biochemical and Biophy... | 5.3K | ✕ |
| 5 | Prions | 1998 | Proceedings of the Nat... | 5.3K | ✕ |
| 6 | Novel Proteinaceous Infectious Particles Cause Scrapie | 1982 | Science | 5.1K | ✕ |
| 7 | Soluble protein oligomers in neurodegeneration: lessons from t... | 2007 | Nature Reviews Molecul... | 4.6K | ✕ |
| 8 | The precursor of Alzheimer's disease amyloid A4 protein resemb... | 1987 | Nature | 4.6K | ✕ |
| 9 | Amyloid plaque core protein in Alzheimer disease and Down synd... | 1985 | Proceedings of the Nat... | 4.4K | ✓ |
| 10 | Common Structure of Soluble Amyloid Oligomers Implies Common M... | 2003 | Science | 4.0K | ✕ |
Frequently Asked Questions
What causes scrapie in sheep and goats?
The scrapie agent causes degenerative central nervous system disease after infection and prolonged incubation. Prusiner (1982) demonstrated in "Novel Proteinaceous Infectious Particles Cause Scrapie" that the agent consists of proteinaceous particles required for infectivity, shown by six lines of evidence including protease sensitivity. No nucleic acid is involved.
How do prions lead to neurodegenerative diseases?
Prions cause invariably fatal neurodegenerative diseases through modification of the prion protein (PrP). Prusiner (1998) explained in "Prions" that diseases present as genetic, infectious, or sporadic, with bovine spongiform encephalopathy as an example. The mechanism involves PrP^C conversion to pathogenic forms.
What role does amyloid β-peptide play in Alzheimer's disease?
Accumulation of amyloid β-peptide (Aβ) in brain plaques drives neurodegeneration in Alzheimer's disease. Hardy and Selkoe (2002) outlined in "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics" that Aβ deposition is the primary influence after over 10 years of proposal. This leads to tau pathology exacerbation.
What is the molecular basis of protein misfolding diseases?
Peptides or proteins convert from soluble to fibrillar aggregates under certain conditions, causing pathological states. Chiti and Dobson (2006) identified in "Protein Misfolding, Functional Amyloid, and Human Disease" diseases ranging from neurodegenerative disorders to systemic amyloidoses associated with such transitions. Oligomers display common structures implying shared pathogenesis mechanisms.
How do amyloid oligomers contribute to tauopathy?
Oligomeric β-amyloid (Aβ) influences tau phosphorylation development. Selenica et al. (2012) investigated in "Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy" intracranially injected Aβ oligomers exacerbating tau pathology in mouse models. Duration of exposure affects outcomes.
What is the structure of soluble amyloid oligomers?
Soluble oligomers across amyloids share a common conformation-dependent structure unique to them. Kayed et al. (2003) showed in "Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis" that this structure represents the primary toxic species, like Aβ in Alzheimer's disease. This implies a unified pathogenesis mechanism.
Open Research Questions
- ? How does the duration of Aβ oligomer exposure quantitatively influence tau phosphorylation levels in tauopathy models?
- ? What specific structural features of PrP^Sc enable templated misfolding of PrP^C without nucleic acids?
- ? Can common conformations of soluble amyloid oligomers be targeted to block pathogenesis across multiple protein misfolding diseases?
- ? What molecular modifications distinguish genetic, infectious, and sporadic prion disease presentations?
- ? How do amyloid plaque core proteins differ in composition between Alzheimer's disease and Down syndrome?
Recent Trends
The field maintains 46,171 works with emphasis on infectious prions, variant Creutzfeldt-Jakob disease, and protein aggregation pathology, as per cluster description.
Prusiner's works from 1982 (5076 citations) and 1998 (5305 citations) anchor ongoing interest in PrP modification and scrapie agents.
No growth rate data or recent preprints/news signal steady incorporation into neurodegenerative studies like Alzheimer's amyloid hypotheses.
Research Prion Diseases and Protein Misfolding with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Prion Diseases and Protein Misfolding with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers